Author:
Sitte Thomas,Thöns Matthias
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Abernethy APCD, Frith P, Fazekas BS, McHugh A, Chuong B (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327:523–528
2. Abernethy AP, McDonald CF, Frith PA et al (2010) Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376:784–793
3. Abrams J (2012) Die lokale Anwendung von Tranexamsäure in der HNO-Chirurgie. HNO 60:1014–1018
4. AWMF: Leitlinie „Empfehlungen zur stationären Therapie von Patienten mit COVID-19“. https://www.awmf.org/leitlinien/detail/ll/113-001LG.html. Zugegriffen: 10. Okt 2022
5. Barnes H, McDonald J, Smallwood N, Manser R (2016) Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.Cochrane Database Syst Rev 3:CD011008